ICP-488

· Beijing InnoCare Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ICP-488, covering 2025-02-28 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study [Phase 2]

See pricing